Clinical Trial Update: Effects of Travoprost on Neovascular Glaucoma [NA]

View source ↗

Summary

A clinical trial evaluating Travoprost for Neovascular glaucoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Glaucoma

Drugs mentioned

• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Federal University of São Paulo | Conditions: Neovascular Glaucoma | NA | Status: WITHDRAWN